Case report: Eosinophilic pneumonia associated with vedolizumab therapy in a patient with ulcerative colitis

Extraintestinal manifestations are common in patients with inflammatory bowel disease, while respiratory involvement is less common. Vedolizumab is a new class of anti-integrin biological agents approved for treating inflammatory bowel disease. In this report, we present the case of a 38-year-old pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wanwan, Zhao, Tianhao, Wei, Jun, Chai, Damin, Zhao, Cancan, Zhu, Yu, Deng, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389358/
https://www.ncbi.nlm.nih.gov/pubmed/35991661
http://dx.doi.org/10.3389/fmed.2022.942237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389358/
https://www.ncbi.nlm.nih.gov/pubmed/35991661
http://dx.doi.org/10.3389/fmed.2022.942237

Ejemplares similares